Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
November 10, 2016 – The FDA approved Merz’s Naftin (naftifine) 2% cream, to include additional data in pediatric subjects aged 2 years to 17 years 11 months with tinea corporis.
